Skip to Main Content

Author Details

Nancy Wang
Massachusetts General Hospital Cancer Center, Harvard Medical School
2013
24
12
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36895918Targeting lung cancer brain metastases: a narrative review of emerging insights for anaplastic lymphoma kinase (<i>ALK</i>)-positive disease.Transl Lung Cancer Res2023
37402650Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.Neuro Oncol2023
36772966Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53.Oncologist2023
35289329Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.Nat Commun2022
34281989Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.J Immunother Cancer2021
35122016Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterations.Nat Cancer2021
34824235Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases.Nat Commun2021
34642329Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.Nat Commun2021
34642316Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases.Nat Commun2021
32483359Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.Nat Med2020
31725902Neurologic complications of melanoma.Cancer2020
32921347Initial Approach to the Patient with Multiple Newly Diagnosed Brain Metastases.Neurosurg Clin N Am2020
32555425Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.Nat Med2020
31314136Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.Cancer2019
29165794Leptomeningeal metastasis from systemic cancer: Review and update on management.Cancer2018
29548058Meningiomas: Overview and New Directions in Therapy.Semin Neurol2018
29681511A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.Cancer Cell2018
28083806New Directions in Anti-Angiogenic Therapy for Glioblastoma.Neurotherapeutics2017
25476169The value of a weekly newsletter in neurology.Pract Neurol2015
24290499Cauda equina involvement in Susac's syndrome.J Neurol Sci2014
29443144SMART syndrome: Stroke-like migraine attack after radiation therapy.Neurol Clin Pract2014
25200715An anomalous developmental venous anomaly.Neurology2014
24381707Reversible palinacousis from intracranial metastases.Neurohospitalist2014
24470954Staphylococcus intermedius infections: case report and literature review.Infect Dis Rep2013
  • 1 - 24 of 24

Recommended Authors

Northwestern University, Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 4
University Health Network, University of Toronto
Career Start Year 2013
Number of shared co-authors 1
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year 2010
Number of shared co-authors 1
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year 2009
Number of shared co-authors 1
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Career Start Year 2004
Number of shared co-authors 0
University of Arkansas for Medical Sciences
Career Start Year 2004
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 4
University of Toronto
Career Start Year 2003
Number of shared co-authors 6
Medical University of Vienna
Career Start Year 2003
Number of shared co-authors 3
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 0
University of California san francisco
Career Start Year 2001
Number of shared co-authors 2
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Johns Hopkins University
Career Start Year 1998
Number of shared co-authors 3
0The Alfred Hospital
Career Start Year 1997
Number of shared co-authors 0
Lenox Hill Hospital
Career Start Year 1997
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
University of Minnesota
Career Start Year 1994
Number of shared co-authors 4
National Cancer Center
Career Start Year 1994
Number of shared co-authors 1
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1994
Number of shared co-authors 1
Neuro-Oncology Clinic, National Cancer Center
Career Start Year 1993
Number of shared co-authors 0
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 0
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 3
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 5
Moffit Cancer Center
Career Start Year 1986
Number of shared co-authors 3
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 1
Rutgers Cancer Institute of New Jersey, Rutgers University
Career Start Year 1984
Number of shared co-authors 1
University of Virginia School of Medicine
Career Start Year 1966
Number of shared co-authors 7

Collaborators

Co-authored papers 12
Harvard Medical School
Co-authored papers 6
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 6
Co-authored papers 6
Brigham and Women's Hospital
Co-authored papers 5
Co-authored papers 3
Co-authored papers 3
Institute for Medical Engineering & Science, Massachusetts Institute of Technology
Co-authored papers 2
Co-authored papers 2
Massachusetts General Hospital Cancer Center
Co-authored papers 2
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 2
University of California san francisco
Co-authored papers 1
Weizmann Institute of Medical Sciences
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Nencki Institute of Experimental Biology of Polish Academy of Sciences
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 1
Innovative Genomics Institute, University of California berkeley
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Barrow Neurological Institute, St. Joseph's Hospital & Medical Center
Co-authored papers 1
Genentech Inc.
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
Institute of Pediatric Hematology and Oncology
Co-authored papers 1
University of Lausanne
Co-authored papers 1
University of California San Francisco
Co-authored papers 1